Drugs Commonly Used in Psychopharmacology and Possible Drug Interactions in Solid Organ Transplant Candidates or Recipients
Özet
Referanslar
Crone CC, Gabriel GM. Treatment of Anxiety and Depression in Transplant Patients. Clin Pharmacokinet. 2004;43:361–394.
Surman OS, Cosimi AB, DiMartini A. Psychiatric care of patients undergoing organ transplantation. Transplantation. 2009;87(12):1753-1761.
FDA Drug Safety Communication: Clarification of dosing and warning recommendations for Celexa. 2016. Available at: http://www.fda.gov/Drugs/ResourcesForYou/SpecialFeatures/ucm297764.htm
Skotzko CE, Rudis R, Kobashigawa JA, Laks H. Psychiatric disorders and outcome following cardiac transplantation. The Journal of heart and lung transplantation. 1999;18(10):952-956.
Kahl KG, Eckermann G, Frieling H, HillemacherT. Psychopharmacology in transplantation medicine. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2019;88:74-85.
Rastogi R, Swarm RA, Patel TA. Case scenario: opioid association with serotonin syndrome: implications to the practitioners. Anesthesiology. 2011;115(6):1291–8.
Lang PO, Hasso Y, Hilleret H, Vogt-Ferrier N. Serotonin syndrome as a result of escitalopram and cyclosporin combination in an 84-year-old woman. La Revue de Medecine Interne.2008;29(7):583-586.
Wong EH, Chan NN, Sze KH, Or KH. Serotonin syndrome in a renal transplant patient. Journal of the Royal Society of Medicine. 2002;95(6):304-305.
Newey CR, Khawam E, Coffman K. Two cases of serotonin syndrome with venlafaxine and calcineurin inhibitors. Psychosomatics.2011;52(3):286-290.
Watanabe N, Omori IM, Nakagawa A, Cipriani A, Barbui C, McGuire H, et al. Multiple Meta-Analyses of New Generation Antidepressants (MANGA) Study Group. Mirtazapine versus other antidepressants in the acute-phase treatment of adults with major depression: systematic review and meta-analysis. The Journal of clinical psychiatry. 2008;69(9):12032.
Özcanlı T, Ünsalver B, Özdemir S, Özmen M. Sertraline and Mirtazapine-Induced Severe Neutropenia- Am J Psychiatry. 2005;162:1386.
DiMartini A, Crone C, Fireman M, Dew MA. Psychiatric aspects of organ transplantation in critical care. Critical care clinics. 2008;24(4):949-981.
Han C, Kim Y. A double-blind trial of risperidone and haloperidol for the treatment of delirium. Psychosomatics. 2004;45(4):297-301.
Sher Y, Zimbrean P. Psychiatric aspects of organ transplantation in critical care: an update. Critical care clinics. 2017;33(3): 659-679.
Rummel-Kluge C, Komossa K, Schwarz S, Hunger H, Schmid F, Lobos CA, et al. Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis. Schizophr Res. 2010;123:225-233.
Coffman KL, Crone C. Rational guidelines for transplantation in patients with psychotic disorders. Current Opinion in Organ Transplantation. 2002;7(4):385-388.
Michelson D, Read HA, Ruff DD, Witcher J, Zhang S, McCracken J. CYP2D6 and clinical response to atomoxetine in children and adolescents with ADHD. Journal of the American Academy of Child & Adolescent Psychiatry. 2007;46(2):242-251.
Shaw RJ,DeMaso DR, editors. Textbook of pediatric psychosomatic medicine. 2010;449–468.
Plutchik L, Snyder S, Drooker M, Chodoff L, Sheiner P. Methylphenidate in post liver transplant patients. Psychosomatics. 1998;39(2):118-123.
Referanslar
Crone CC, Gabriel GM. Treatment of Anxiety and Depression in Transplant Patients. Clin Pharmacokinet. 2004;43:361–394.
Surman OS, Cosimi AB, DiMartini A. Psychiatric care of patients undergoing organ transplantation. Transplantation. 2009;87(12):1753-1761.
FDA Drug Safety Communication: Clarification of dosing and warning recommendations for Celexa. 2016. Available at: http://www.fda.gov/Drugs/ResourcesForYou/SpecialFeatures/ucm297764.htm
Skotzko CE, Rudis R, Kobashigawa JA, Laks H. Psychiatric disorders and outcome following cardiac transplantation. The Journal of heart and lung transplantation. 1999;18(10):952-956.
Kahl KG, Eckermann G, Frieling H, HillemacherT. Psychopharmacology in transplantation medicine. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2019;88:74-85.
Rastogi R, Swarm RA, Patel TA. Case scenario: opioid association with serotonin syndrome: implications to the practitioners. Anesthesiology. 2011;115(6):1291–8.
Lang PO, Hasso Y, Hilleret H, Vogt-Ferrier N. Serotonin syndrome as a result of escitalopram and cyclosporin combination in an 84-year-old woman. La Revue de Medecine Interne.2008;29(7):583-586.
Wong EH, Chan NN, Sze KH, Or KH. Serotonin syndrome in a renal transplant patient. Journal of the Royal Society of Medicine. 2002;95(6):304-305.
Newey CR, Khawam E, Coffman K. Two cases of serotonin syndrome with venlafaxine and calcineurin inhibitors. Psychosomatics.2011;52(3):286-290.
Watanabe N, Omori IM, Nakagawa A, Cipriani A, Barbui C, McGuire H, et al. Multiple Meta-Analyses of New Generation Antidepressants (MANGA) Study Group. Mirtazapine versus other antidepressants in the acute-phase treatment of adults with major depression: systematic review and meta-analysis. The Journal of clinical psychiatry. 2008;69(9):12032.
Özcanlı T, Ünsalver B, Özdemir S, Özmen M. Sertraline and Mirtazapine-Induced Severe Neutropenia- Am J Psychiatry. 2005;162:1386.
DiMartini A, Crone C, Fireman M, Dew MA. Psychiatric aspects of organ transplantation in critical care. Critical care clinics. 2008;24(4):949-981.
Han C, Kim Y. A double-blind trial of risperidone and haloperidol for the treatment of delirium. Psychosomatics. 2004;45(4):297-301.
Sher Y, Zimbrean P. Psychiatric aspects of organ transplantation in critical care: an update. Critical care clinics. 2017;33(3): 659-679.
Rummel-Kluge C, Komossa K, Schwarz S, Hunger H, Schmid F, Lobos CA, et al. Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis. Schizophr Res. 2010;123:225-233.
Coffman KL, Crone C. Rational guidelines for transplantation in patients with psychotic disorders. Current Opinion in Organ Transplantation. 2002;7(4):385-388.
Michelson D, Read HA, Ruff DD, Witcher J, Zhang S, McCracken J. CYP2D6 and clinical response to atomoxetine in children and adolescents with ADHD. Journal of the American Academy of Child & Adolescent Psychiatry. 2007;46(2):242-251.
Shaw RJ,DeMaso DR, editors. Textbook of pediatric psychosomatic medicine. 2010;449–468.
Plutchik L, Snyder S, Drooker M, Chodoff L, Sheiner P. Methylphenidate in post liver transplant patients. Psychosomatics. 1998;39(2):118-123.
